tradingkey.logo

iRhythm Technologies Inc

IRTC
View Detailed Chart

176.160USD

-3.660-2.04%
Close 09/15, 16:00ETQuotes delayed by 15 min
5.66BMarket Cap
LossP/E TTM

iRhythm Technologies Inc

176.160

-3.660-2.04%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.04%

5 Days

-5.83%

1 Month

+9.70%

6 Months

+74.99%

Year to Date

+95.36%

1 Year

+129.94%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-15

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
17 / 207
Overall Ranking
101 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 13 analysts
Buy
Current Rating
180.364
Target Price
+0.30%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 44.03% year-on-year.
Undervalued
The company’s latest PE is -60.15, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 36.46M shares, decreasing 6.64% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 3.23M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Ticker SymbolIRTC
CompanyiRhythm Technologies Inc
CEOMr. Quentin S. Blackford
Websitehttps://www.irhythmtech.com/
KeyAI